EIPICO Destination

Report a side effect Contact Us

Who We Are

Who We Are
EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
Manufacturing Facilities

Manufacturing Facilities
EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
Science & Medicine

Science & Medicine
EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
Global

Global
EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
Investor Relations

Investor Relations
- Investor Relations
- Annual Reports
EIPICO 3

EIPICO 3
The First Modular Biological and Biosimilar Facility in Egypt
- EIPICO 3 (Biologicals & Biosimilars)

We're sorry, but our website doesn't work properly without JavaScript enabled.

Global / Eipico Destination

Egypt

EIPICO produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.

Afghanistan

Albania

Algeria

Armenia

Azerbaijan

Bahrain

Belarus

Burundi

Chad

Chile

Colombia

Comoros

Djibouti

Ecuador

Eritrea

Ethiopia

Georgia

Ghana

Guinea

Hong Kong

Iraq

Ireland

Jamaica

Jordan

Kazakhstan

Kenya

Kosovo

Kurdistan

Kuwait

Kyrgyzstan

Lebanon

Libya

Malaysia

Mali

Moldova

Mozambique

Myanmar

Niger

Nigeria

Oman

...
Previous
1
2
Next
...
Pages count = 2
All items count = 66

WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

EIPICO 3
News
Products
Global accreditation
Global
Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top

Powered by EIPICO Team

Visitors Count : 1331152